Oracle Investment Management as of June 30, 2015
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 27 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 17.0 | $140M | 5.4M | 25.81 | |
| Opko Health (OPK) | 9.7 | $80M | 5.0M | 16.08 | |
| Quidel Corporation | 8.1 | $67M | 2.9M | 22.95 | |
| Thoratec Corp Com New | 6.6 | $55M | 1.2M | 44.57 | |
| NxStage Medical | 6.2 | $51M | 3.6M | 14.29 | |
| Chimerix (CMRX) | 5.8 | $47M | 1.0M | 46.20 | |
| Raptor Pharaceuticals | 5.5 | $45M | 2.8M | 15.79 | |
| Intrexon | 5.2 | $43M | 877k | 48.80 | |
| Hansen Medical | 5.0 | $41M | 45M | 0.92 | |
| Mazor Robotics Sponsored Ads | 3.9 | $33M | 2.4M | 13.31 | |
| shares Agenus | 3.7 | $31M | 3.6M | 8.63 | |
| Tesaro | 3.5 | $29M | 493k | 58.79 | |
| Acorda Therapeutics | 3.3 | $27M | 816k | 33.33 | |
| Accuray Incorporated (ARAY) | 2.6 | $21M | 3.2M | 6.74 | |
| Pacific Biosciences of California (PACB) | 2.3 | $19M | 3.2M | 5.76 | |
| Biolase Technology | 2.2 | $18M | 11M | 1.74 | |
| Vermillion Com New | 2.0 | $17M | 8.1M | 2.07 | |
| Amarin Corp Spons Adr New (AMRN) | 1.5 | $13M | 5.2M | 2.46 | |
| WebMD Health | 1.3 | $11M | 238k | 44.28 | |
| Transition Therapeutics Com New | 1.2 | $10M | 4.9M | 2.10 | |
| Regulus Therapeutics | 1.0 | $8.1M | 742k | 10.96 | |
| Contrafect | 0.8 | $6.2M | 1.2M | 5.25 | |
| Metabolix | 0.5 | $4.3M | 1.2M | 3.75 | |
| Biogen Idec (BIIB) | 0.4 | $3.1M | 7.7k | 403.99 | |
| ZIOPHARM Oncology | 0.4 | $2.9M | 242k | 12.00 | |
| Second Sight Med Prods | 0.3 | $2.9M | 210k | 13.61 | |
| Ladenburg Thalmann Financial Services | 0.0 | $210k | 60k | 3.50 |
